NRX Pharmaceuticals (NRXP) Non-Current Assets (2017 - 2026)
NRX Pharmaceuticals (NRXP) reported Non-Current Assets of $5 million for Q2 2026, compared with $248,000 a year earlier and up 10.1% from the prior quarter.
Powered by 
Analysis
NRX Pharmaceuticals (NRXP) Non-Current Assets (2017 - 2026) Analysis & Trends
At the end of FY2025, NRX Pharmaceuticals posted Non-Current Assets of $4.06 million.
- Non-Current Assets has a five-year compound annual growth rate of 226.7% (FY2020 to FY2025).
- By year, Non-Current Assets came in at $349,000 in FY2024 (-19.0%), $431,000 in FY2023, $21,000 in FY2022 (+40.0%) and $15,000 in FY2021 (+37.4%).
- The Q2 2026 figure ranks as the highest quarterly Non-Current Assets since Q1 2021.
- Year over year, Non-Current Assets gained in 1 of the last four quarters, with growth averaging 169.4%.
- The high point for year-over-year Non-Current Assets in five years was Q3 2025 (growth of 756.5%); the low point was Q3 2021 (a decline of 99.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $4.54 million (Q1 2026), $4.06 million (Q4 2025) and $3.05 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 14.88 Bn |
| 10 | NRX Pharmaceuticals | 126.02 Mn | 77.61 Mn | 426,000.00 | 5.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.00 Mn |
| Mar 31, 2026 | 4.54 Mn |
| Dec 31, 2025 | 4.06 Mn |
| Sep 30, 2025 | 3.05 Mn |
| Jun 30, 2025 | 248,000.00 |
| Mar 31, 2025 | 334,000.00 |
| Dec 31, 2024 | 349,000.00 |
| Sep 30, 2024 | 356,000.00 |
| Jun 30, 2024 | 384,000.00 |
| Mar 31, 2024 | 441,000.00 |
| Dec 31, 2023 | 431,000.00 |
| Sep 30, 2023 | 21,000.00 |
| Jun 30, 2023 | 21,000.00 |
| Mar 31, 2023 | 24,000.00 |
| Dec 31, 2022 | 21,000.00 |
| Sep 30, 2022 | 23,000.00 |
| Jun 30, 2022 | 19,000.00 |
| Mar 31, 2022 | 17,000.00 |
| Dec 31, 2021 | 15,000.00 |
| Sep 30, 2021 | 15,921.00 |
API Access
NRX Pharmaceuticals Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=NRXP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "NRXP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=NRXP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();